There is 1 paper on cardiocerebrovascular events in aging research: 1 trial in people.
1 paper studies it2 more mention it1 finding
See all 3 papers on cardiocerebrovascular events
“Moreover, the overall incidence of acute cardiocerebrovascular events was lower in the observation group than in the control group.”
- Human trial1
Associations
1Simvastatin
downin humans1
1 study
Simvastatin
downin humans1
Simvastatin lowers the risk of cardiocerebrovascular events in humans (carotid atherosclerotic plaque).
“Moreover, the overall incidence of acute cardiocerebrovascular events was lower in the observation group than in the control group.”
Human trialcarotid atherosclerotic plaquetablet20 mg/dayn = 65
Experimental and therapeutic medicine
Latest
1 paper in 12 monthsExperimental and Therapeutic Medicine
Efficacy of simvastatin on carotid atherosclerotic plaque and its effects on serum inflammatory factors and cardiocerebrovascular events in elderly patients
Randomized trial in 130 peopleSimvastatin
Frontiers in Endocrinology
Linking the triglyceride-glucose index to major adverse cardiocerebrovascular events in individuals with cardiovascular-kidney-metabolic syndrome: insights from an aggregate-data systematic review and dose-response meta-analysis
Meta-analysis of observational studiesTriglyceride-glucose index